Key result
LIMP-2 loss in mice prevents adaptive hypertrophy and drives cardiomyopathy during increased blood pressure.
Why the study?
The role of lysosomal integral membrane protein 2 (LIMP-2) in cardiac intercalated discs and its importance in load-induced cardiac myocyte hypertrophy was not established.
Does LIMP-2 mediate the adaptive hypertrophic response to cardiac loading in cardiac myocytes?
Does LIMP-2 mediate the adaptive hypertrophic response to cardiac loading in cardiac myocytes?
LIMP-2 is a novel component of the cardiac intercalated disc that is essential for the adaptive hypertrophic response to cardiac loading.
LIMP-2 loss blunts adaptive hypertrophy in murine pressure overload; leaves open its role in human cardiomyopathy.
The intercalated disc (ID) of cardiac myocytes is emerging as a crucial structure in the heart. Loss of ID proteins like N-cadherin causes lethal cardiac abnormalities, and mutations in ID proteins cause human cardiomyopathy. A comprehensive screen for novel mechanisms in failing hearts demonstrated that expression of the lysosomal integral membrane protein 2 (LIMP-2) is increased in cardiac hypertrophy and heart failure in both rat and human myocardium. Complete loss of LIMP-2 in genetically engineered mice did not affect cardiac development; however, these LIMP-2 null mice failed to mount a hypertrophic response to increased blood pressure but developed cardiomyopathy. Disturbed cadherin localization in these hearts suggested that LIMP-2 has important functions outside lysosomes. Indeed, we also find LIMP-2 in the ID, where it associates with cadherin. RNAi-mediated knockdown of LIMP-2 decreases the binding of phosphorylated beta-catenin to cadherin, whereas overexpression of LIMP-2 has the opposite effect. Collectively, our data show that LIMP-2 is crucial to mount the adaptive hypertrophic response to cardiac loading. We demonstrate a novel role for LIMP-2 as an important mediator of the ID.
No takes yet. Share an insight, caveat, or question.
Schroen et al. (2007) studied Cardiac hypertrophy and heart failure. LIMP-2 genetic manipulation (knockout/knockdown/overexpression) vs. Wild-type/control was evaluated on Hypertrophic response to increased blood pressure and cardiomyopathy development. Complete loss of LIMP-2 in genetically engineered mice prevented the adaptive hypertrophic response to increased blood pressure and led to the development of cardiomyopathy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: